ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Immunosuppressants and lupus nephritis"

  • Abstract Number: 747 • ACR/ARHP Annual Meeting 2016

    The Long-Term Outcomes on Leflunomide Treatment in Patients with Lupus Nephritis: A Twelve-Year Follow-up Study

    Minjun Wang1, Gong Yinhua2 and Fei Xiao3, 1Gothic Internet Technology Corporation, Shanghai, China, 2Cinkate Pharmaceutical Corporation, Shanghai, China, 3Cinkate Corporation, Shanghai, China

    Background/Purpose: Leflunomide(LEF) is an effective immunosuppressant. In China, one phase III study has reported that compared with cyclophosphamide, LEF in combination with prednisone was effective in the induction…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology